Trial Profile
Placebo-Controlled Confirmatory Study of Galantamine(R113675) for Alzheiner Type Dementia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 May 2013
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 30 Apr 2013 Actual initiation date changed from Jan 2006 to Feb 2007, as reported by ClinicalTrials.gov.
- 20 Jan 2010 Actual number of patients changed from 997 to 580 as reported by ClinicalTrials.gov.
- 10 Sep 2009 Actual patient number (997) added as reported by ClinicalTrials.gov.